These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38360380)

  • 1. Ethyl cinnamate suppresses tumor growth through anti-angiogenesis by attenuating VEGFR2 signal pathway in colorectal cancer.
    Wang S; Yang J; Kuang X; Li H; Du H; Wu Y; Xu F; Liu B
    J Ethnopharmacol; 2024 May; 326():117913. PubMed ID: 38360380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent anti-angiogenic component in Kaempferia galanga L. and its mechanism of action.
    Huang W; Zheng N; Niu N; Tan Y; Li Y; Tian H
    J Ethnopharmacol; 2024 Apr; 324():117811. PubMed ID: 38286156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyperenoic acid, a sesquiterpene derivative from Croton crassifolius, inhibits tumor growth through anti-angiogenesis by attenuating VEGFR2 signal pathway in breast cancer.
    Huang W; Liang Y; Chung HY; Wang G; Huang JJ; Li Y
    Phytomedicine; 2020 May; 76():153253. PubMed ID: 32531699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-angiogenic activity and mechanism of kaurane diterpenoids from Wedelia chinensis.
    Huang W; Liang Y; Wang J; Li G; Wang G; Li Y; Chung HY
    Phytomedicine; 2016 Mar; 23(3):283-92. PubMed ID: 26969382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Oncotarget; 2016 Sep; 7(39):63124-63137. PubMed ID: 27517319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oleanolic Acid Inhibits Colorectal Cancer Angiogenesis by Blocking the VEGFR2 Signaling Pathway.
    Niu G; Sun L; Pei Y; Wang D
    Anticancer Agents Med Chem; 2018; 18(4):583-590. PubMed ID: 29065844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
    Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
    Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cultivated Orostachys japonicus extract inhibits VEGF-induced angiogenesis via regulation of VEGFR2 signaling pathway in vitro and in vivo.
    Cho HD; Lee KW; Won YS; Kim JH; Seo KI
    J Ethnopharmacol; 2020 Jun; 256():112664. PubMed ID: 32045685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coral-derived compound WA-25 inhibits angiogenesis by attenuating the VEGF/VEGFR2 signaling pathway.
    Lin SW; Huang SC; Kuo HM; Chen CH; Ma YL; Chu TH; Bee YS; Wang EM; Wu CY; Sung PJ; Wen ZH; Wu DC; Sheu JH; Tai MH
    Mar Drugs; 2015 Feb; 13(2):861-78. PubMed ID: 25668036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin-4'-O-β-D-glucopyranoside (QODG) inhibits angiogenesis by suppressing VEGFR2-mediated signaling in zebrafish and endothelial cells.
    Lin C; Wu M; Dong J
    PLoS One; 2012; 7(2):e31708. PubMed ID: 22348123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-angiogenic activity of para-coumaric acid methyl ester on HUVECs in vitro and zebrafish in vivo.
    Zhang HZ; Li CY; Wu JQ; Wang RX; Wei P; Liu MH; He MF
    Phytomedicine; 2018 Sep; 48():10-20. PubMed ID: 30195867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
    Li X; Wang X; Ye H; Peng A; Chen L
    Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two natural eudesmane-type sesquiterpenes from Laggera alata inhibit angiogenesis and suppress breast cancer cell migration through VEGF- and Angiopoietin 2-mediated signaling pathways.
    Liang N; Li Y; Chung HY
    Int J Oncol; 2017 Jul; 51(1):213-222. PubMed ID: 28534941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2-mediated angiogenesis.
    Saraswati S; Kanaujia PK; Kumar S; Kumar R; Alhaider AA
    Mol Cancer; 2013 Jul; 12():82. PubMed ID: 23895055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The extract of Curcumae Longae Rhizoma suppresses angiogenesis via VEGF-induced PI3K/Akt-eNOS-NO pathway.
    Guo GX; Wu KY; Zhang XY; Lai FX; Tsim KW; Qin QW; Hu WH
    J Ethnopharmacol; 2023 May; 308():116299. PubMed ID: 36842721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
    Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
    Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPemd26, an anthraquinone derivative, suppresses angiogenesis via inhibiting VEGFR2 signalling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Br J Pharmacol; 2014 Dec; 171(24):5728-42. PubMed ID: 25091695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling.
    Awasthi N; Schwarz MA; Verma V; Cappiello C; Schwarz RE
    Lab Invest; 2009 Jan; 89(1):38-46. PubMed ID: 19002109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antrodia cinnamomea produces anti-angiogenic effects by inhibiting the VEGFR2 signaling pathway.
    Huang TT; Lan YW; Ko YF; Chen CM; Lai HC; Ojcius DM; Martel J; Young JD; Chong KY
    J Ethnopharmacol; 2018 Jun; 220():239-249. PubMed ID: 29609012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis.
    Bi YL; Mi PY; Zhao SJ; Pan HM; Li HJ; Liu F; Shao LR; Zhang HF; Zhang P; Jiang SL
    Int J Mol Med; 2017 May; 39(5):1255-1261. PubMed ID: 28358414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.